Hancock Whitney’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,190
Closed -$124K 821
2021
Q1
$124K Hold
12,190
﹤0.01% 749
2020
Q4
$91K Buy
+12,190
New +$91K ﹤0.01% 774